Podium to Practice: EHA 2025 – Leukemia: QUANTUM-FIRST

Podium to Practice: EHA 2025 – Leukemia: QUANTUM-FIRST

Podium to Practice: EHA 2025
Explore more from your favourite experts – click their name to access their entire library of content.
Icon Chair Speaker

Chair

Dr. Julie Bergeron

Icon Chair Speaker

Speakers

Dr. Brian Leber

Dr. Danielle Hammond

Studies / Trials Discussed

S140 – THE COMBINATION OF A FLT3-ITD, NPM1MUT AND AN EPIGENETIC REGULATORY GENE MUTATION CONFERS UNIQUE SENSITIVITY TO QUIZARTINIB: ANALYSIS FROM THE QUANTUM-FIRST TRIAL

Studies/trials discussed:

S140 – THE COMBINATION OF A FLT3-ITD, NPM1MUT AND AN EPIGENETIC REGULATORY GENE MUTATION CONFERS UNIQUE SENSITIVITY TO QUIZARTINIB: ANALYSIS FROM THE QUANTUM-FIRST TRIAL
Tagged